Table of Contents
- Introduction to Glucosamine
- What Is Glucosamine?
- Is There Any Research?
- Is Glucosamine Safe?
Introduction to Glucosamine
Glucosamine is a supplement that most of us have heard of.
A recent report from the U.S. National Center for Health Statistics found that Americans spend around $13 billion per year on natural product supplements (1). Of these, glucosamine is one of the most popular dietary supplements.
Why the Huge Interest in Glucosamine?
Well, an estimated 27 million adults in the United States alone live with osteoarthritis, the most common type of arthritis, which is especially prevalent among “older” people (2).
Osteoarthritis, also called degenerative joint disease, is caused by the breakdown of cartilage, which is the hard but slippery connective tissue that cushions the ends of bones where they meet to form a joint.
The condition is characterized by pain, joint damage, stiffness, and limited motion, and most commonly affects the hands and large weight-bearing joints, such as the knees, hips, and back (3). In fact, osteoarthritis is often associated with significant disability and impaired quality of life as a result (4).
And herein lies its popularity: many patients with osteoarthritis are driven by pain caused by the condition to try any treatment; others are seeking a “natural” treatment (1).
What Is Glucosamine?
Glucosamine is a structural component of cartilage tissue, which is found in the joints. It is an amino sugar produced naturally in the body (5).
Glucosamine (in the form of glucosamine hydrochloride, to be precise) is also available as a dietary supplement; in fact, it is one of the most popular dietary supplements on the market. In the United States, glucosamine is sold as a dietary supplement; therefore, it is regulated as food rather than a drug.
Is There Any Research?
Yes. Lots. Researchers have studied the effects of glucosamine supplements, both individually and in combination with other chemicals, on osteoarthritis, because of its prevalence and disabling effects on patients.
A lot of good-quality research has been conducted into the safety and usefulness of glucosamine with large, high-quality studies in humans. Most clinical trials have focused on its use in osteoarthritis of the knee.
There are 372 clinical trials involving glucosamine listed on PubMed. It is important to note that many of the studies of glucosamine supplementation were conducted in conjunction with other chemicals. Of these 372 clinical trials, 349 are studies in humans, the remaining being in animals.
Does Glucosamine Improve Osteoarthritis?
The vast majority of research conducted on glucosamine supplementation has been into its effects on osteoarthritis.
There has been a fierce controversy about the efficacy of glucosamine, chondroitin (another component of cartilage), or the two in combination in the treatment of knee osteoarthritis.
Major studies of glucosamine for osteoarthritis of the knee have had conflicting results. It’s unclear whether glucosamine helps with osteoarthritis knee pain or whether either supplement lessens osteoarthritis pain in other joints.
A few studies have looked at whether glucosamine or chondroitin can have beneficial effects on joint structure. There is little evidence that glucosamine has beneficial effects on joint structure.
The GAIT Study Clinical Trial
The largest clinical trial so far, the 2006 Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT), sponsored by the National Institutes of Health (NIH), showed conflicting and somewhat confusing results (6, 7, 8).
The study was conducted because it was agreed that there was a real and urgent public health need to test glucosamine (and two other agents) in a rigorous, scientific way, for pain control and functional improvement of osteoarthritis.
A total of 1,583 people participated in the study, at a cost of just over $12.5 million. The GAIT study was the largest randomized, double-blind, placebo-controlled study involving glucosamine, and it still has not confirmed whether the supplement is effective in the treatment of osteoarthritis.
Participants were evaluated at the start of the study and at weeks 4, 8, 16, and 24 of treatment. They were closely monitored for improvement of their symptoms as well as for any possible adverse reactions. X-rays documented each participant’s diagnosis of osteoarthritis.
The study found that glucosamine alone, or in combination with chondroitin (another component of cartilage), did not reduce pain in the overall group, although it did appear to lessen pain among those with moderate-to-severe osteoarthritis of the knee.
It also raised questions for further research in certain disease subgroups. Researchers are now studying whether the glucosamine-chondroitin combination may help people with more severe osteoarthritis.
The second phase of GAIT, conducted in 2008, looked at participants who continued with the study for another 28 months. They were tested to see whether glucosamine or chondroitin (together or alone) slowed the loss of cartilage in their knees. Interestingly, results showed no difference in cartilage loss compared with those who took a placebo.
As a result of so much conflicting research, experts have disagreed on whether glucosamine may help knee and hip osteoarthritis. The American College of Rheumatology (ACR) has recommended that people with knee or hip osteoarthritis not use glucosamine… But the recommendation was not a strong one, and the ACR acknowledged that it was controversial. The clinical practice guideline of the American Academy of Orthopaedic Surgeons also states that the use of glucosamine cannot be recommended. With such conflicting research results, there is no clear evidence to recommend its use.
The recommendation is that if doctors have patients who wish to try glucosamine, it would be reasonable to support a 60-day trial of glucosamine sulfate. The decision to continue therapy can then be left to patients on an individual basis while monitoring for possible adverse effects.
The Zeng et Al. Study Meta-Analysis
Conversely, in the largest meta-analysis conducted to date, pooling all the available data, Zeng et al. compared glucosamine, chondroitin, and the two in combination with celecoxib (an osteoarthritis treatment) or placebo for the treatment of knee osteoarthritis (9).
A total of 54 studies covering 16,427 patients were included.
The results indicated significant effects of glucosamine plus chondroitin in pain relief and function improvement compared to the placebo group. But… researchers concluded that the effects of glucosamine, chondroitin, or the two in combination remained uncertain due to the weakness of the evidence.
What About Research in Osteoarthritis in Other Joints?
Only a small amount of research has been done on glucosamine for osteoarthritis of joints other than the knee and hip, for example, the hand, jaw, and spine. Because there have only been a few and relatively small studies, no definite conclusions can be reached.
Does It Improve Digestion?
No research has been done to investigate the effect of glucosamine on digestion.
Does It Help Inflammatory Bowel Disease?
Extremely weak evidence. Just one preliminary study has been conducted on the effects of glucosamine on inflammatory bowel disease. Conducted by Salvatore et al. in 2000, the study involved just 12 children (10).
Eight of the 12 children treated showed clear clinical improvement when orally administered glucosamine was added to their current treatment, while four failed to respond. Of the seven children treated with rectally administered glucosamine enema as single therapy, five showed clear improvement and two did not respond.
The study demonstrated preliminary results for the clinical efficacy of glucosamine on inflammatory bowel disease; however, the strength of supporting evidence was limited by its study design and sample size.
The researchers noted that it was an open-label study, limited by ethical considerations to a population of children with severe or treatment-resistant disease. Rigorous formal, large, placebo-controlled clinical studies are necessary to confirm its efficacy and determine indications for use on inflammatory bowel disease.
Does It Help TMJ Symptoms?
Weak evidence. There are around five good research studies that have suggested glucosamine as an effective treatment for TMJ disorders involving osteoarthritis of the jaw. However, these studies were limited to 200 or fewer patients per study, which means that the evidence remains weak (11).
Other studies have found that those taking glucosamine did no better than those taking a placebo. More large, randomized clinical trials are needed to demonstrate sufficient evidence to assert whether glucosamine has a positive effect on TMJ symptoms.
Does It Help Alleviate Bone Pain?
No research has been conducted into the effects of glucosamine on bone pain itself. Research has rather looked at osteoarthritic pain in joints (see above).
Is Glucosamine Safe?
According to the NIH, the reported adverse effects have been relatively well studied and are generally uncommon and minor (5). No serious side effects have been reported in large, well-conducted research studies of people taking glucosamine for up to 3 years.
To put it into perspective, there were 77 reports of serious adverse effects during the GAIT study of almost 1,600 participants. Of those 77, only 3 were attributed to study treatments. Most side effects were mild, such as an upset stomach, and were spread evenly across the two treatment groups.
However, glucosamine should be used with caution in patients who have shellfish allergies or asthma, and in those taking diabetes medications or warfarin.
Patients taking the following medications should not use glucosamine or make any adjustments to their medications without first talking to their doctor.
- Glucosamine may increase the blood-thinning effect of Warfarin (coumadin) and may increase the risk of bruising or bleeding, which can be serious.
- Glucosamine may reduce the dose of nonsteroidal anti-inflammatory drugs (NSAIDs) taken for osteoarthritis pain relief. Since NSAIDs can cause stomach bleeding, reducing the dose can be helpful.
- Glucosamine might affect the way your body metabolizes sugar, especially if you are diabetic or have other blood sugar problems, such as insulin resistance or impaired glucose tolerance.
- Glucosamine may negatively interact with cancer medications such as Doxorubicin, Etoposide, and Teniposide. There is some concern that glucosamine may increase cell growth, which is the exact opposite of what these treatments are designed to do.
- As always, pregnant or nursing women should talk to their doctor before taking any medication or supplement.
The assumption that taking a glucosamine supplement will increase the amount of cartilage in joints is certainly an interesting one. At best, glucosamine does not cause adverse effects, subject to it being taken under the supervision of a doctor.
Evidence-wise, there is little to suggest that oral glucosamine is beneficial for osteoarthritis. Due to inconclusive evidence, the American College of Rheumatology does not currently recommend glucosamine for the treatment of osteoarthritis.
Despite this, glucosamine supplements (alone or in combination) may work for some people with osteoarthritis. It is therefore advised that patients who take these supplements and who have seen improvements with them should not stop taking them.
It is also recommended that people with osteoarthritis work with their doctor to develop a comprehensive plan for managing their arthritis pain, with lifestyle modification (eat right, exercise, lose excess weight) and proven pain medications.
- Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, Jordan JM, Katz JN, Kremers HM, Wolfe F. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II. Arthritis Rheum. 2008 Jan;58(1):26-35.
- NIH National Institutes of Health: Osteoarthritis (osteoarthritis) https://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0024679/
- Towheed T, Maxwell L, Anastassiades TP, Shea B, Houpt JB, Welch V, Hochberg MC, Wells GA. Glucosamine therapy for treating osteoarthritis. Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD002946. DOI: 10.1002/14651858.CD002946.pub2.
- NIH National Institutes of Health: Glucosamine and Chondroitin for Osteoarthritis https://nccih.nih.gov/health/glucosaminechondroitin
- Questions and Answers: NIH Glucosamine/Chondroitin Arthritis Intervention Trial Primary Study https://nccih.nih.gov/research/results/gait/qa.htm
- Clegg DO, Reda DJ, Harris CL, Klein MA, O’Dell JR, Hooper MM, Bradley JD, Bingham CO 3rd, Weisman MH, Jackson CG, Lane NE, Cush JJ, Moreland LW, Schumacher HR Jr, Oddis CV, Wolfe F, Molitor JA, Yocum DE, Schnitzer TJ, Furst DE, Sawitzke AD, Shi H, Brandt KD, Moskowitz RW, Williams HJ. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006 Feb 23;354(8):795-808.
- Sawitzke AD, Shi H, Finco MF, Dunlop DD, Bingham CO 3rd, Harris CL, Singer NG, Bradley JD, Silver D, Jackson CG, Lane NE, Oddis CV, Wolfe F, Lisse J, Furst DE, Reda DJ, Moskowitz RW, Williams HJ, Clegg DO. The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial. Arthritis Rheum. 2008 Oct;58(10):3183-91. doi: 10.1002/art.23973.
- 9 Zeng C, Wei J, Li H, Wang YL, Xie DX, Yang T, Gao SG, Li YS, Luo W, Lei GH. Effectiveness and safety of Glucosamine, chondroitin, the two in combination, or celecoxib in the treatment of osteoarthritis of the knee. Sci Rep. 2015 Nov 18;5:16827. doi: 10.1038/srep16827.
- Salvatore S, Heuschkel R, Tomlin S, Davies SE, Edwards S, Walker-Smith JA, French I, Murch SH. (2000), A pilot study of N-acetyl glucosamine, a nutritional substrate for glycosaminoglycan synthesis, in paediatric chronic inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 14: 1567–1579. doi:10.1046/j.1365-2036.2000.00883.x
- Haghighat A, Behnia A, Kaviani N, Khorami B. Evaluation of Glucosamine sulfate and Ibuprofen effects in patients with temporomandibular joint osteoarthritis symptom. Journal of Research in Pharmacy Practice. 2013;2(1):34-39. doi:10.4103/2279-042X.114087.